BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18684063)

  • 1. Pharmacogenomics of brain cancer and personalized medicine in malignant gliomas.
    Shai RM; Reichardt JK; Chen TC
    Future Oncol; 2008 Aug; 4(4):525-34. PubMed ID: 18684063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of gene expression profiles in malignant brain tumors with respect to sensitivity to therapies].
    Yamanaka R; Morii K; Takahashi H; Tanaka R; Nishio K
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():49-54. PubMed ID: 16201499
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of p16 and p14ARF in radio- and chemosensitivity of malignant gliomas.
    Simon M; Voss D; Park-Simon TW; Mahlberg R; Köster G
    Oncol Rep; 2006 Jul; 16(1):127-32. PubMed ID: 16786135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetic markers as predictors of response to chemotherapy in gliomas.
    Idbaih A; Omuro A; Ducray F; Hoang-Xuan K
    Curr Opin Oncol; 2007 Nov; 19(6):606-11. PubMed ID: 17906460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New glioma therapy using specific microRNAs].
    Halle B; Andersen C; Schulz MK; Kristensen BW
    Ugeskr Laeger; 2012 Mar; 174(10):630-3. PubMed ID: 22395010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer.
    Danesi R; de Braud F; Fogli S; de Pas TM; Di Paolo A; Curigliano G; Del Tacca M
    Pharmacol Rev; 2003 Mar; 55(1):57-103. PubMed ID: 12615954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New treatment strategies for malignant gliomas.
    Sathornsumetee S; Rich JN
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface receptors in malignant glioma.
    Li YM; Hall WA
    Neurosurgery; 2011 Oct; 69(4):980-94; discussion 994. PubMed ID: 21522029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics in cancer treatment.
    Nagasubramanian R; Innocenti F; Ratain MJ
    Annu Rev Med; 2003; 54():437-52. PubMed ID: 12525681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic pharmacogenomics in cancer.
    Ikediobi ON
    Pharmacogenomics J; 2008 Oct; 8(5):305-14. PubMed ID: 18679398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA repair and resistance of gliomas to chemotherapy and radiotherapy.
    Frosina G
    Mol Cancer Res; 2009 Jul; 7(7):989-99. PubMed ID: 19609002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics in breast cancer: current trends and future directions.
    Wajapeyee N; Somasundaram K
    Curr Opin Mol Ther; 2004 Jun; 6(3):296-301. PubMed ID: 15264432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of microRNAs to radio- and chemoresistance of brain tumors and their therapeutic potential.
    Chistiakov DA; Chekhonin VP
    Eur J Pharmacol; 2012 Jun; 684(1-3):8-18. PubMed ID: 22484336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics and pharmacogenomics of diffuse gliomas.
    van Thuijl HF; Ylstra B; Würdinger T; van Nieuwenhuizen D; Heimans JJ; Wesseling P; Reijneveld JC
    Pharmacol Ther; 2013 Jan; 137(1):78-88. PubMed ID: 22985521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman R
    Biotechniques; 2005 Oct; 39(10 Suppl):S565-8. PubMed ID: 18957038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive pharmacogenomics characterization of temozolomide response in gliomas.
    Tong S; Wang Y; Wu J; Long J; Zhong P; Wang B
    Eur J Pharmacol; 2021 Dec; 912():174580. PubMed ID: 34678239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics for individualized cancer chemotherapy.
    Efferth T; Volm M
    Pharmacol Ther; 2005 Aug; 107(2):155-76. PubMed ID: 15890408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecularly targeted therapies for malignant gliomas: advances and challenges.
    Penas-Prado M; Gilbert MR
    Expert Rev Anticancer Ther; 2007 May; 7(5):641-61. PubMed ID: 17492929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy for gliomas based on the expression levels of drug resistant genes].
    Matsumoto Y; Morisaki K; Miyake K; Kawanishi M; Kawai N; Ogawa T; Irie K; Kunishio K; Nagao S
    No Shinkei Geka; 2001 Jul; 29(7):625-30. PubMed ID: 11517503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics and pharmacogenomics: a clinical reality.
    Ferraldeschi R; Newman WG
    Ann Clin Biochem; 2011 Sep; 48(Pt 5):410-7. PubMed ID: 21733927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.